PANDALAM, India (Reuters) - Stuck in a village in southern India for nine months and unable to return to his job in Saudi Arabia, Sugathan P.R. is hoping the World Health Organization will approve the Indian COVID-19 shot Covaxin, paving the way for his trip back. Like Sugathan, millions of Indians have taken Covaxin and many have complained of travel struggles as the vaccine has not been recognised for international travel by several countries. Without a WHO nod, the two-dose Covaxin is unlikely to be accepted as a valid vaccine globally and would complicate travel plans for Indians who have taken it. "I can buy a ticket to Kuwait only if the Kuwait government app shows a green signal."
